JP2002500043A - アポトーシス誘導分子ｉｉ - Google Patents

アポトーシス誘導分子ｉｉ

Info

Publication number
JP2002500043A
JP2002500043A JP2000527646A JP2000527646A JP2002500043A JP 2002500043 A JP2002500043 A JP 2002500043A JP 2000527646 A JP2000527646 A JP 2000527646A JP 2000527646 A JP2000527646 A JP 2000527646A JP 2002500043 A JP2002500043 A JP 2002500043A
Authority
JP
Japan
Prior art keywords
amino acid
aim
polypeptide
seq
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000527646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002500043A5 (https=
Inventor
レインハード エブナー，
スティーブン エム． ルーベン，
ガオ−リャン ユ，
スティーブン ウルリッチ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2002500043A publication Critical patent/JP2002500043A/ja
Publication of JP2002500043A5 publication Critical patent/JP2002500043A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000527646A 1998-01-07 1999-01-07 アポトーシス誘導分子ｉｉ Withdrawn JP2002500043A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US388698A 1998-01-07 1998-01-07
US09/027,287 US6479254B2 (en) 1996-03-22 1998-02-20 Apoptosis inducing molecule II
US09/027,287 1998-02-20
US09/003,886 1998-02-20
PCT/US1999/000242 WO1999035262A2 (en) 1998-01-07 1999-01-07 Apoptosis inducing molecule ii

Publications (2)

Publication Number Publication Date
JP2002500043A true JP2002500043A (ja) 2002-01-08
JP2002500043A5 JP2002500043A5 (https=) 2006-02-23

Family

ID=26672322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000527646A Withdrawn JP2002500043A (ja) 1998-01-07 1999-01-07 アポトーシス誘導分子ｉｉ

Country Status (6)

Country Link
US (1) US6479254B2 (https=)
EP (1) EP1044270A2 (https=)
JP (1) JP2002500043A (https=)
AU (1) AU2106399A (https=)
CA (1) CA2317057A1 (https=)
WO (1) WO1999035262A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US6140467A (en) * 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US7118742B2 (en) * 1997-07-07 2006-10-10 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6998108B1 (en) 1997-07-07 2006-02-14 La Jolla Institute For Allergy And Immunology Antibodies to p30 polypeptides and methods making and using same
ATE460482T1 (de) * 1997-09-17 2010-03-15 Mochida Pharm Co Ltd Fas-liganden derivate
CA2374273A1 (en) * 1999-05-21 2000-11-30 Takeda Chemical Industries, Ltd. Liver function controlling agents
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
DE60143231D1 (de) * 2000-04-12 2010-11-18 Jolla Inst Allergy Immunolog Ligand des zelleintritt-vermittelnden Proteins von Herpes Simplex und Methoden zu dessen Verwendungen
WO2002066049A1 (fr) * 2001-02-23 2002-08-29 Takeda Chemical Industries, Ltd. Agents pour changement plasmique
CA2439193A1 (en) * 2001-02-23 2002-08-29 Hideki Matsui Casoase 3 inhibitors
EP1376134A1 (en) * 2002-06-28 2004-01-02 Universitätsklinikum Charité Medizinische Fakultät der Humboldt-Universität zu Berlin A method of screening for TRAIL-inhibitors
AT412145B (de) * 2002-09-13 2004-10-25 Forsch Krebskranke Kinder Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen
EP2322200A3 (en) * 2002-10-29 2011-07-27 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2007290570C1 (en) 2006-08-28 2013-08-15 Kyowa Kirin Co., Ltd. Antagonistic human LIGHT-specific human monoclonal antibodies
US9694058B2 (en) * 2006-10-25 2017-07-04 La Jolla Institute For Allergy And Immunology Light-mediated anti-cell proliferative compositions and methods
WO2010051502A2 (en) * 2008-10-31 2010-05-06 Biogen Idec Ma Inc. Light targeting molecules and uses thereof
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
JPH08211695A (ja) 1992-12-14 1996-08-20 Canon Inc 画像形成装置の帯電部材
US5534881A (en) 1994-08-31 1996-07-09 Hughes Aircraft Company Microwave filter assembly having a nonsymmetrical waveguide and an antenna
WO1996036720A1 (en) 1995-05-16 1996-11-21 Bristol-Myers Squibb Company Recombinant heregulins and their biological functions upon receptor activation
JPH0919330A (ja) 1995-07-07 1997-01-21 Manhin Denki Seisakusho:Kk キッチンキャビネットのスイッチ装置
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
CA2248868A1 (en) 1996-03-22 1997-09-25 Human Genome Sciences, Inc. Apoptosis inducing molecule ii
DE69730607T2 (de) 1996-07-19 2005-01-27 Takeda Chemical Industries, Ltd. Fas ligand ähnliches protein, seine herstellung und verwendung
WO1998025967A1 (en) 1996-12-12 1998-06-18 Genentech, Inc. Hvem polypeptides and uses thereof
DE69740107D1 (de) 1996-12-23 2011-03-10 Immunex Corp Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie
US6010853A (en) 1997-05-29 2000-01-04 Dana-Farber Cancer Institute Siva genes, novel genes involved in CD27-mediated apoptosis
US6140467A (en) 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
WO1999011662A1 (en) 1997-09-05 1999-03-11 Millennium Biotherapeutics, Inc. Novel molecules of the tnfr-ligand-related protein family and uses thereof
AU2972199A (en) 1998-02-20 1999-09-06 Reinhard Ebner Apoptosis inducing molecule ii and methods of use

Also Published As

Publication number Publication date
WO1999035262A2 (en) 1999-07-15
EP1044270A2 (en) 2000-10-18
CA2317057A1 (en) 1999-07-15
US6479254B2 (en) 2002-11-12
WO1999035262A3 (en) 1999-12-02
AU2106399A (en) 1999-07-26
US20020064869A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
JP2002500043A (ja) アポトーシス誘導分子ｉｉ
KR100497017B1 (ko) 고사유도분자ii
US20040147733A1 (en) Fc receptors and polypeptides
US20040175790A1 (en) Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
JP2001510035A (ja) インターロイキン−２０
KR20050004269A (ko) 뉴트로킨 알파
AU6496699A (en) Interleukin 17-like receptor protein
WO1998031806A9 (en) Fc RECEPTORS AND POLYPEPTIDES
US5942417A (en) CD44-like protein and nucleic acids
US20020150989A1 (en) Human tumor necrosis factor receptor
JP2002504333A (ja) アポトーシス誘導分子ｉｉおよび使用方法
JP2001502912A (ja) ヒト腫瘍壊死因子レセプター―ライク２
JP2002507125A (ja) カルジオトロフィン様サイトカイン
JP2001509663A (ja) ヒト腫瘍壊死因子レセプター様遺伝子
US20030166097A1 (en) Human tumor necrosis factor receptor
JP2002508166A (ja) ヒトＤｅｎｄｒｉａｃおよびＢｒａｉｎｉａｃ−３
AU734384B2 (en) Apoptosis inducing molecule II
US20040047864A1 (en) Apoptosis inducing molecule I
AU771013B2 (en) Apoptosis inducing molecule II
US8110659B1 (en) Human tumor necrosis factor receptor-like genes
AU2004212622C1 (en) A Tumor Necrosis Factor Related Ligand
US20030105058A1 (en) CD44-like protein
EP1712631A2 (en) Fc receptors and polypeptides
AU2004202460A1 (en) Apoptosis Inducing Molecule II
HK1111195A (en) NEUTROKINE α

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051222

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20060329